Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1Genitourinary 1CNS 1Breast 1

Conditions

Myelodysplastic Syndromes 48Leukemia, Myeloid, Acute 43Precursor Cell Lymphoblastic Leukemia-Lymphoma 26Leukemia, Myelogenous, Chronic, BCR-ABL Positive 22Leukemia 19Hodgkin Disease 18Lymphoma, Non-Hodgkin 17Multiple Myeloma 14Leukemia, Lymphocytic, Chronic, B-Cell 13Primary Myelofibrosis 12Leukemia, Myelomonocytic, Chronic 11Myeloproliferative Disorders 10Lymphoma 10Graft vs Host Disease 8Leukemia, Biphenotypic, Acute 7Leukemia, Myelomonocytic, Juvenile 6Polycythemia Vera 4Lymphoma, Follicular 4Leukemia, Myeloid, Accelerated Phase 4Hemoglobinuria, Paroxysmal 4Anemia, Aplastic 4Thrombocythemia, Essential 3Neoplasms 3Lymphoma, Mantle-Cell 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, B-Cell, Marginal Zone 3Hematologic Neoplasms 3Hematologic Diseases 3Blast Crisis 3Anemia, Refractory, with Excess of Blasts 3

Interventions

fludarabine phosphate 18Cyclophosphamide 18Peripheral Blood Stem Cell Transplantation 17Busulfan 17Tacrolimus 14Methotrexate 14Mycophenolic Acid 12Antilymphocyte Serum 12Cyclosporine 11Whole-Body Irradiation 9Flow Cytometry 9Filgrastim 7Etoposide 7Radiotherapy 6Methylprednisolone 6Melphalan 6Cord Blood Stem Cell Transplantation 6Therapeutics 5Psychiatric Rehabilitation 5Polymerase Chain Reaction 5Sirolimus 4Immunoenzyme Techniques 4thymoglobulin 3Rituximab 3Ondansetron 3Immunologic Techniques 3Early Intervention, Educational 3Cytarabine 3Cyclosporins 3Aprepitant 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pdgfra-Associated Chronic Eosinophilic Leukemia × Stem Cell Transplantation × Myeloid × Clear all
NCT00617929 2017-12-28

Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant

Masonic Cancer Center, University of Minnesota

Phase 2 Terminated
12 enrolled 12 charts
BreastCNSGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Pdgfra-Associated Chronic Eosinophilic Leukemia, Carcinoma, Ovarian Epithelial, Breast Neoplasms, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Hairy Cell, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Neoplasms, Wilms Tumor, Neuroblastoma, Recurrence, Rhabdomyosarcoma, Testicular Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡